COPD Flashcards
What causes COPD?
Inhalation of cigarette smoke and other noxious particles or gas, which triggers an abnormal inflammatory response in the lung
Result of chronic inflammatory response?
Emphysema (lung tissue destruction)
Small airway narrowing and fibrosis (alter normal repair and defense mech)
When should a clinical diagnose be considered in any pt?
Dyspnea (SOB, which is chronic and progressive)
Chronic cough or sputum production
Hx of exposure to risk factors of COPD, esp, cigarette smoke
What’s req for COPD diagnosis?
Spirometry (ways to measure breathing)
What confirms the presence of persistent airflow limitation and thus COPD?
Presence of a post-bronchodilator FEV1/FVC < 0.70
What’s the only mgt strategy proven to slow progression of COPD?
Smoking cessation
List other imp mgt strategies of COPD
Vaccinations
Pulmonary rehabilitation programs
Drug therapies (often using inhalers)
Some req long-term oxygen therapy
Lung transplantation (rarely done)
List risk factors of COPD
Smoking or smoke exposure
Alpha-1 antitrypsin deficiency
Occupational dusts and chemicals (chemical agents and fumes)
Indoor and outdoor air pollution
Howz COPD assessed?
Sx
Degree of airflow limitation (using spirometry)
Risk of exacerbations
Comorbidities
How do u classify severity of airflow limitation in COPD (in pts with FEV1/FVC < 0.70)?
GOLD 1 - Mild - FEV1 >= 80% predicted
GOLD 2 - Moderate - 50% =< FEV1 < 80% predicted
GOLD 3 - Severe - 30% =< FEV1 < 50% predicted
GOLD 4 - Very Severe - FEV1 < 30% predicted
What factors make up the GOLD 1 classification of severity of airflow limitation in COPD (based on Post-Bronchodilator FEV1; in pts with FEV1/FVC < 0.70)?
Severity = Mild
Airflow = FEV1 >= 80% predicted
What factors make up the GOLD 2 classification of severity of airflow limitation in COPD (based on Post-Bronchodilator FEV1; in pts with FEV1/FVC < 0.70)?
Severity = Moderate
Airflow = 50% =< FEV1 < 80% predicted
What factors make up the GOLD 3 classification of severity of airflow limitation in COPD (based on Post-Bronchodilator FEV1; in pts with FEV1/FVC < 0.70)?
Severity = Severe
Airflow = 30% =< FEV1 < 50% predicted
What factors make up the GOLD 4 classification of severity of airflow limitation in COPD (based on Post-Bronchodilator FEV1; in pts with FEV1/FVC < 0.70)?
Severity = Very Severe
Airflow = FEV1 < 30% predicted
List comorbidities that may influence mortality and hospitalizations and should be looked for routinely and treated appropriately.
Cardiovascular dx
Osteoporosis
Depression and anxiety
Skeletal muscle dysfunction
Metabolic syndrome
Lung cancer
How do u choose risk of COPD?
When assessing risk, chose the highest risk according to GOLD grade or exacerbation hx
List xteristics of patient A wrt:
Xtics Spirometric classification Exacerbation per year mMRC CAT
Xtics - low risk & sx
Spirometric classification - GOLD 1-2
Exacerbations per year - =< 1 per yr
mMRC - 0-1
CAT - < 10
List xteristics of patient B wrt:
Xtics Spirometric classification Exacerbation per year mMRC CAT
Xtics - low risk & MORE sx
Spirometric classification - GOLD 1-2
Exacerbations per year - =< 1 per yr
mMRC - >= 2
CAT - >=10
List xteristics of patient C wrt:
Xtics Spirometric classification Exacerbation per year mMRC CAT
Xtics - HIGH risk & Less sx
Spirometric classification - GOLD 3-4
Exacerbations per year - >= 2 per yr
mMRC - 0-1
CAT - <10
List xteristics of patient D wrt:
Xtics Spirometric classification Exacerbation per year mMRC CAT
Xtics - HIGH risk & more sx
Spirometric classification - GOLD 3-4
Exacerbations per year - >= 2 per yr
mMRC - >= 2
CAT - >= 10
What’s the pharmacologic therapy for stable COPD pt grp A?
Recommended first choice
Alternative choice
Other possible tx
Patient group A
Recommended first choice - SA anticholinergic PRN or SA beta-
agonist PRN
Alternative choice - LA anticholinergic or LA beta-agonist or SA beta-
agonist and SA anticholinergic
Other possible tx - Theophylline
What’s the pharmacologic therapy for stable COPD pt grp B?
Recommended first choice
Alternative choice
Other possible tx
Patient group B
Recommended first choice - LA anticholinergic or
LA beta2-agonist
Alternative choice - LA beta 2-agonist and LA anticholinergic
Other possible tx - SA beta-agonist and/or SA anticholinergic
Theophylline
What’s the pharmacologic therapy for stable COPD pt grp C?
Recommended first choice
Alternative choice
Other possible tx
Patient group C
Recommended first choice - LA anticholinergic or
ICS (inhaled corticosteroid) + LA beta2-
agonist
Alternative choice - LA beta2-agonist and LA anticholinergic or
LA anticholinergic and PDE-4 inhibitor or
LA beta2-agonist and PDE-4 inhibitor
Other possible tx - SA beta2-agonist and/or SA anticholinergic
Theophylline
What’s the pharmacologic therapy for stable COPD pt grp D?
Recommended first choice
Alternative choice
Other possible tx
Patient group D
Recommended first choice - LA anticholinergic and/or
ICS (inhaled corticosteroid) + LA beta2-
agonist
Alternative choice - ICS + LA beta2-agonist and LA anticholinergic or
LA anticholinergic and LA beta2-agonist or
ICS + LA beta2-agonist and PDE-4 inhibitor
LA anticholinergic and PDE-4 inhibitor
Other possible tx - Carbocysteine
SA beta2-agonist and/or SA anticholinergic
Theophylline
Uses of meds in COPD?
Used to decrease sx and/or complications (no medication had been shown to modify the long-term decline in lung fxn)